Neil Gow

Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom.

East African Tea Investments provides investment and business support services. The non-profit company is based in Aberdeen, UK and was founded in 2012.

Part of Süddeutsche Zuckerrübenverwertungs-Genossenschaft eG, Aquifer Ltd. is a holding company. The company is based in Leatherhead, UK.

Part of Norwich BioScience Institutes, NBI Partnership Ltd. was founded in 2012 and is based in Norwich, UK. The British company provides non-scientific services to the John Innes Centre, the Earlham Institute, the Sainsbury Laboratory, and Quadram Institute Bioscience, supporting world-class research in biological sciences. The company's website includes a privacy policy and information about their services, institutes, vacancies, and a map. The website also uses cookies to improve user experience and analyze website usage.

Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey.

Plant Bioscience Ltd. operates as an independent technology management company. The firm specializes in plant, food and microbial science. Its services include identification of opportunities, enhancement and protection of technology, commercialization strategy and business development. The company was founded in 1994 and is headquartered in Norwich, the United Kingdom.

Norwich Biosciences Ltd. engages in the research and development on natural sciences and engineering. The company was founded on July 6, 1995 and is headquartered in Norwich, the United Kingdom.

John Innes Centre Ltd. provides research services in plant science and microbiology. It carries out fundamental research to train scientists and make their findings available to society. The scientific research at the center makes use of a range of disciplines in the biological and chemical sciences, including cell biology, biochemistry, genetics, molecular biology, computational and mathematical biology. The company was founded in 1910 and is headquartered in Norwich, the United Kingdom.

Chiltern International Group Ltd. operates as a holding company with interests in providing clinical development and other outsourced services to the pharmaceutical, medical device and biotechnology industries. The company was founded on May 23, 2006 and is headquartered in Edinburgh, the United Kingdom.

Agency For Science Technology & Research Ventures is a Venture Capital firm, a subsidiary of Agency for Science, Technology & Research founded in 1991 with headquartered in Singapore.

Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore.

Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom.

Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom.

Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million.

Part of BenevolentAI SA, BenevolentAI Bio Ltd. is a clinical-stage AI-enabled drug discovery and British development company founded in 2013. The company is based in London, UK. BenevolentAI Bio uses AI to augment scientific ingenuity in the drug discovery process, from target identification to clinical development, with the goal of improving the probability of clinical success. The company has refined and formalized its approach to sustainability under the direction of the newly established environmental, social, and governance (ESG) governance structure and teams. BenevolentAI Bio's AI-enabled Benevolent Platform™ empowers scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.

Chiltern International, Inc. provides clinical research services. It offers clinical development, medical and scientific affairs, data and analysis, pharmacovigilance and strategic regulatory services. The firm serves biotech, pharmaceuticals, biosimilars and biologics and medical device and diagnostics industries. The company was founded in 1982 and is headquartered in Slough, the United Kingdom.

Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom.

The Big C Appeal Ltd. is a cancer charity that provides support to anyone affected by cancer, from diagnosis and treatment to life beyond cancer. The charity is proud to be a part of the innovative Norwich Research Park, with their head office located alongside the research institutes they fund. The non-profit company is based in Norwich, UK, and the CEO is Christopher Bushby. The British company offers research grant applications, a research advisory panel, and a peer review process to ensure excellent research governance. The company works closely with NNUH, James Paget University Hospital, and The Queen Elizabeth Hospital. Big C was founded in 1980 by David Moar and Clive Bamford, and it is the largest cancer charity in the area.